Molecular characterization of synovial sarcoma in children and adolescents: Evidence of Akt activation

Fabio Bozzi, Andrea Ferrari, Tiziana Negri, Elena Conca, Da Riva Luca, Marco Losa, Paola Casieri, Marta Orsenigo, Andrea Lampis, Cristina Meazza, Michela Casanova, Marco A. Pierotti, Elena Tamborini, Silvana Pilotti

Research output: Contribution to journalArticle

Abstract

Synovial sarcoma (SS) is the most frequent nonrhabdomyosarcomatous soft tissue sarcoma encountered in adolescents and young adults, and despite advances in the treatment of local disease, metastases remain the main cause of death. The aim of this study was to characterize a single-center series of pediatric SS molecularly to seek any biomarkers or pathways that might make suitable targets for new agents. Seventeen cases of pediatric SS showing the SYT-SSX fusion transcript were screened immunohistochemically, biochemically, molecularly, and cytogenetically (depending on the available material) to investigate any expression/activation of epidermal growth factor receptor, platelet-derived growth factor receptor alpha (PDGFRα), PDGFRβ, Akt, and deregulated Wnt pathway. The most relevant outcome was the finding of activated epidermal growth factor receptor, PDGFRα, and PDGFRβ, which activated Akt in both the monophasic and biphasic histologic subtypes. Consistently, Akt activation was completely abolished in an SS cell line assay when stimulated by PDGF-AA and treated with the phosphatidylinositol 3-kinase inhibitor LY294002. Our results also showed the nuclear localization of β-catenin and cyclin D1 gene products in monophasic SS and the movement of β-catenin into the cytoplasm in the glandular component of the biphasic subtype. Although they need to be confirmed in larger series, these preliminary data suggest that therapeutic strategies including specific inhibitors of the phosphatidylinositol 3-kinase/Akt pathway might be exploited in SS.

Original languageEnglish
Pages (from-to)95-101
Number of pages7
JournalTranslational Oncology
Volume1
Issue number2
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Synovial Sarcoma
Platelet-Derived Growth Factor alpha Receptor
Phosphatidylinositol 3-Kinase
Catenins
Epidermal Growth Factor Receptor
bcl-1 Genes
Pediatrics
Wnt Signaling Pathway
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Sarcoma
Young Adult
Cause of Death
Cytoplasm
Biomarkers
Neoplasm Metastasis
Cell Line
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Molecular characterization of synovial sarcoma in children and adolescents : Evidence of Akt activation. / Bozzi, Fabio; Ferrari, Andrea; Negri, Tiziana; Conca, Elena; Luca, Da Riva; Losa, Marco; Casieri, Paola; Orsenigo, Marta; Lampis, Andrea; Meazza, Cristina; Casanova, Michela; Pierotti, Marco A.; Tamborini, Elena; Pilotti, Silvana.

In: Translational Oncology, Vol. 1, No. 2, 06.2008, p. 95-101.

Research output: Contribution to journalArticle

Bozzi, Fabio ; Ferrari, Andrea ; Negri, Tiziana ; Conca, Elena ; Luca, Da Riva ; Losa, Marco ; Casieri, Paola ; Orsenigo, Marta ; Lampis, Andrea ; Meazza, Cristina ; Casanova, Michela ; Pierotti, Marco A. ; Tamborini, Elena ; Pilotti, Silvana. / Molecular characterization of synovial sarcoma in children and adolescents : Evidence of Akt activation. In: Translational Oncology. 2008 ; Vol. 1, No. 2. pp. 95-101.
@article{8c43a2e295f6471fa4996d0d427843ef,
title = "Molecular characterization of synovial sarcoma in children and adolescents: Evidence of Akt activation",
abstract = "Synovial sarcoma (SS) is the most frequent nonrhabdomyosarcomatous soft tissue sarcoma encountered in adolescents and young adults, and despite advances in the treatment of local disease, metastases remain the main cause of death. The aim of this study was to characterize a single-center series of pediatric SS molecularly to seek any biomarkers or pathways that might make suitable targets for new agents. Seventeen cases of pediatric SS showing the SYT-SSX fusion transcript were screened immunohistochemically, biochemically, molecularly, and cytogenetically (depending on the available material) to investigate any expression/activation of epidermal growth factor receptor, platelet-derived growth factor receptor alpha (PDGFRα), PDGFRβ, Akt, and deregulated Wnt pathway. The most relevant outcome was the finding of activated epidermal growth factor receptor, PDGFRα, and PDGFRβ, which activated Akt in both the monophasic and biphasic histologic subtypes. Consistently, Akt activation was completely abolished in an SS cell line assay when stimulated by PDGF-AA and treated with the phosphatidylinositol 3-kinase inhibitor LY294002. Our results also showed the nuclear localization of β-catenin and cyclin D1 gene products in monophasic SS and the movement of β-catenin into the cytoplasm in the glandular component of the biphasic subtype. Although they need to be confirmed in larger series, these preliminary data suggest that therapeutic strategies including specific inhibitors of the phosphatidylinositol 3-kinase/Akt pathway might be exploited in SS.",
author = "Fabio Bozzi and Andrea Ferrari and Tiziana Negri and Elena Conca and Luca, {Da Riva} and Marco Losa and Paola Casieri and Marta Orsenigo and Andrea Lampis and Cristina Meazza and Michela Casanova and Pierotti, {Marco A.} and Elena Tamborini and Silvana Pilotti",
year = "2008",
month = "6",
doi = "10.1593/tlo.08121",
language = "English",
volume = "1",
pages = "95--101",
journal = "Translational Oncology",
issn = "1936-5233",
publisher = "Neoplasia Press",
number = "2",

}

TY - JOUR

T1 - Molecular characterization of synovial sarcoma in children and adolescents

T2 - Evidence of Akt activation

AU - Bozzi, Fabio

AU - Ferrari, Andrea

AU - Negri, Tiziana

AU - Conca, Elena

AU - Luca, Da Riva

AU - Losa, Marco

AU - Casieri, Paola

AU - Orsenigo, Marta

AU - Lampis, Andrea

AU - Meazza, Cristina

AU - Casanova, Michela

AU - Pierotti, Marco A.

AU - Tamborini, Elena

AU - Pilotti, Silvana

PY - 2008/6

Y1 - 2008/6

N2 - Synovial sarcoma (SS) is the most frequent nonrhabdomyosarcomatous soft tissue sarcoma encountered in adolescents and young adults, and despite advances in the treatment of local disease, metastases remain the main cause of death. The aim of this study was to characterize a single-center series of pediatric SS molecularly to seek any biomarkers or pathways that might make suitable targets for new agents. Seventeen cases of pediatric SS showing the SYT-SSX fusion transcript were screened immunohistochemically, biochemically, molecularly, and cytogenetically (depending on the available material) to investigate any expression/activation of epidermal growth factor receptor, platelet-derived growth factor receptor alpha (PDGFRα), PDGFRβ, Akt, and deregulated Wnt pathway. The most relevant outcome was the finding of activated epidermal growth factor receptor, PDGFRα, and PDGFRβ, which activated Akt in both the monophasic and biphasic histologic subtypes. Consistently, Akt activation was completely abolished in an SS cell line assay when stimulated by PDGF-AA and treated with the phosphatidylinositol 3-kinase inhibitor LY294002. Our results also showed the nuclear localization of β-catenin and cyclin D1 gene products in monophasic SS and the movement of β-catenin into the cytoplasm in the glandular component of the biphasic subtype. Although they need to be confirmed in larger series, these preliminary data suggest that therapeutic strategies including specific inhibitors of the phosphatidylinositol 3-kinase/Akt pathway might be exploited in SS.

AB - Synovial sarcoma (SS) is the most frequent nonrhabdomyosarcomatous soft tissue sarcoma encountered in adolescents and young adults, and despite advances in the treatment of local disease, metastases remain the main cause of death. The aim of this study was to characterize a single-center series of pediatric SS molecularly to seek any biomarkers or pathways that might make suitable targets for new agents. Seventeen cases of pediatric SS showing the SYT-SSX fusion transcript were screened immunohistochemically, biochemically, molecularly, and cytogenetically (depending on the available material) to investigate any expression/activation of epidermal growth factor receptor, platelet-derived growth factor receptor alpha (PDGFRα), PDGFRβ, Akt, and deregulated Wnt pathway. The most relevant outcome was the finding of activated epidermal growth factor receptor, PDGFRα, and PDGFRβ, which activated Akt in both the monophasic and biphasic histologic subtypes. Consistently, Akt activation was completely abolished in an SS cell line assay when stimulated by PDGF-AA and treated with the phosphatidylinositol 3-kinase inhibitor LY294002. Our results also showed the nuclear localization of β-catenin and cyclin D1 gene products in monophasic SS and the movement of β-catenin into the cytoplasm in the glandular component of the biphasic subtype. Although they need to be confirmed in larger series, these preliminary data suggest that therapeutic strategies including specific inhibitors of the phosphatidylinositol 3-kinase/Akt pathway might be exploited in SS.

UR - http://www.scopus.com/inward/record.url?scp=67649698279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649698279&partnerID=8YFLogxK

U2 - 10.1593/tlo.08121

DO - 10.1593/tlo.08121

M3 - Article

AN - SCOPUS:67649698279

VL - 1

SP - 95

EP - 101

JO - Translational Oncology

JF - Translational Oncology

SN - 1936-5233

IS - 2

ER -